Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines

about

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines

Item

http://www.wikidata.org/entity/Q35928588

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Percutaneous Vaccination as an ...... MVA and MVA-Vectored Vaccines

@ast

Percutaneous Vaccination as an ...... MVA and MVA-Vectored Vaccines

@en

type

Item

label

Percutaneous Vaccination as an ...... MVA and MVA-Vectored Vaccines

@ast

Percutaneous Vaccination as an ...... MVA and MVA-Vectored Vaccines

@en

prefLabel

Percutaneous Vaccination as an ...... MVA and MVA-Vectored Vaccines

@ast

Percutaneous Vaccination as an ...... MVA and MVA-Vectored Vaccines

@en

P1476

Percutaneous Vaccination as an ...... MVA and MVA-Vectored Vaccines

@en

P2093

Clement A Meseda

http://www.w3.org/2001/XMLSchema#string

Falko Schmeisser

http://www.w3.org/2001/XMLSchema#string

Jerry P Weir

http://www.w3.org/2001/XMLSchema#string

Jordan Kuhn

http://www.w3.org/2001/XMLSchema#string

Vajini Atukorale

http://www.w3.org/2001/XMLSchema#string

P2860

Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity

Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination

Microneedle array design determines the induction of protective memory CD8+ T cell responses induced by a recombinant live malaria vaccine in mice

Coated microneedles for transdermal delivery

Needle-free vaccine delivery

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.

Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene

ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.

P304

e0149364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0149364

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295244561

http://www.w3.org/2001/XMLSchema#string

P698

26895072

http://www.w3.org/2001/XMLSchema#string

P932

4760941

http://www.w3.org/2001/XMLSchema#string